Company Profile

Systemix Inc
Profile last edited on: 9/7/12      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1990
First Award
1990
Latest Award
1991
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3155 Porter Drive
Palo Alto, CA 94304
   (415) 856-4901
   N/A
   N/A
Location: Single
Congr. District: 18
County: Santa Clara

Public Profile

In February 1997, Systemix Inc was acquired by Novartis AG. SyStemix, Inc. is a biotechnology company leading in the development of therapies for major disorders of the blood and the immune system based on the use of isolated, expanded and gene-modified human hematopoietic stem cells.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1991 1 NIH $50,000
Project Title: Testing of HIV Vaccines in SCID-HU Mice
1990 1 NIH $50,000
Project Title: Long term human hemotopoiesis in the scid-hu mouse
1990 1 NIH $50,000
Project Title: Cultivation/Identification of human hematopoietic cell

Key People / Management

  Reiko Namikawa

  Linda Rabin

  Ann S Tsukamoto

Company News

There are no news available.